Skip to main content

Table 1 Metabolic parameters

From: Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice

  Control GH1-treated control Alcohol GH1-treated alcohol Pair-fed I Pair-fed II
BAC (mmol/l) - - 22.13 ± 2.28 16.20 ± 1.54### - -
β-OHB (μmol/l) 88.5 ± 10.48d 246.4 ± 41.2a 122.7 ± 15.36c 164.53 ± 19.80b 94.87 ± 10.43d 92.80 ± 11.98d
TG (mmol/l) 1.24 ± 0.31 1.13 ± 0.13 1.54 ± 0.22* 1.16 ± 0.28 1.15 ± 0.25 1.17 ± 0.32
TC (mmol/l) 4.04 ± 0.48 3.95 ± 0.36 3.91 ± 0.47 3.99 ± 0.60 4.10 ± 0.35 4.08 ± 0.28
IGF-1 (ng/ml) 393.95 ± 46.65 415.32 ± 39.97 384.53 ± 38.75 400.55 ± 50.78 399.05 ± 34.67 387.37 ± 21.68
Insulin (μU/ml) 24.90 ± 2.19 25.89 ± 2.45 24.47 ± 1.92 25.60 ± 2.43 24.60 ± 1.88 24.76 ± 2.42
Glucose (mmol/l) 6.46 ± 0.36 6.85 ± 0.45 6.23 ± 0.25 6.79 ± 0.42 6.32 ± 0.43 6.28 ± 0.47
HOMA-IR 7.14 ± 0.56 7.85 ± 0.61* ## 6.78 ± 0.62 7.71 ± 0.38* # 6.92 ± 0.92 6.88 ± 0.47
TNFα (pg/ml) 8.50 ± 2.03# 7.95 ± 1.75## 10.83 ± 2.07* 8.77 ± 1. 94# 8.20 ± 1.77# 8.80 ± 1.93#
Hepatic MDA (μM) 3.39 ± 1.09 2.27 ± 0.67* ## 3.77 ± 1.03 2.87 ± 0.81 3.17 ± 0.92 3.05 ± 0.59
  1. n = 6 mice per group. *P < 0.05 vs. the control group; #P < 0.05, ##P < 0.01 or ###P < 0.001 vs. the alcohol group. HOMA-IR: homeostasis model assessment of insulin resistance; MDA: malondialdehyde; β-OHB: β-hydroxybutyrate; TC: total cholesterol; TG: triglyceride; TNFα: tumor necrosis factor-α.